Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intracameral Antibiotic Safety Study

NCT02590523 is registered in ClinicalTrials.gov with Panhandle Eye Group, LLP as lead sponsor.

NCT NCT02590523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02590523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intracameral Antibiotic Safety Study
Lead sponsor
Panhandle Eye Group, LLP
Phase
Phase 3
Overall status
Suspended
Start date
January 31, 2023
Completion date
January 31, 2024
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cataract surgery, endophthalmitis, intracameral antibiotics, moxifloxacin, phacoemulsification, vancomycin